600713 南京医药
已收盘 08-24 15:00:00
资讯
新帖
简况
每周股票复盘：南京医药（600713）非独立董事离任
证券之星 · 08-23 02:53
每周股票复盘：南京医药（600713）非独立董事离任
南京医药（600713）披露非独立董事离任公告，8月21日股价下跌3.17%
证券之星 · 08-21 22:15
南京医药（600713）披露非独立董事离任公告，8月21日股价下跌3.17%
每周股票复盘：南京医药（600713）发行两期融资券共10亿
证券之星 · 07-19
每周股票复盘：南京医药（600713）发行两期融资券共10亿
南京医药（600713）披露2026年度第十期超短期融资券发行结果公告，7月15日股价上涨0.56%
证券之星 · 07-15
南京医药（600713）披露2026年度第十期超短期融资券发行结果公告，7月15日股价上涨0.56%
南京医药（600713）披露2026年度第二期中期票据发行结果公告，7月13日股价上涨0.59%
证券之星 · 07-13
南京医药（600713）披露2026年度第二期中期票据发行结果公告，7月13日股价上涨0.59%
每周股票复盘：南京医药（600713）控股子公司签署7.47亿元投资协议
证券之星 · 07-12
每周股票复盘：南京医药（600713）控股子公司签署7.47亿元投资协议
南京医药（600713）披露控股子公司对外投资进展暨签署相关投资协议公告，7月10日股价上涨0.79%
证券之星 · 07-10
南京医药（600713）披露控股子公司对外投资进展暨签署相关投资协议公告，7月10日股价上涨0.79%
南京医药（600713）披露控股子公司对外投资进展公告，7月7日股价下跌3.68%
证券之星 · 07-07
南京医药（600713）披露控股子公司对外投资进展公告，7月7日股价下跌3.68%
南京医药：公司后续将从四方面发力优化市值表现
证券之星 · 07-02
南京医药：公司后续将从四方面发力优化市值表现
每周股票复盘：南京医药（600713）南药转债转股价调至4.95元
证券之星 · 06-28
每周股票复盘：南京医药（600713）南药转债转股价调至4.95元
南京医药（600713）披露与私募基金合作投资事项进展公告，6月25日股价上涨2.17%
证券之星 · 06-25
南京医药（600713）披露与私募基金合作投资事项进展公告，6月25日股价上涨2.17%
南京医药（600713）发布关于因实施权益分派调整可转债转股价格的公告，6月23日股价上涨4.0%
证券之星 · 06-23
南京医药（600713）发布关于因实施权益分派调整可转债转股价格的公告，6月23日股价上涨4.0%
南京医药跨界投资折戟：一场“已读不回”背后的三大隐忧
新浪证券 · 06-12
南京医药跨界投资折戟：一场“已读不回”背后的三大隐忧
股市必读：南京医药（600713）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：南京医药（600713）6月1日董秘有最新回复
南京医药：公司2026年3月末股东总数为47,508人
证券之星 · 06-01
南京医药：公司2026年3月末股东总数为47,508人
每周股票复盘：南京医药（600713）拟设并购基金出资不超4.5亿
证券之星 · 05-31
每周股票复盘：南京医药（600713）拟设并购基金出资不超4.5亿
南京医药（600713）披露召开2026年第三次临时股东会提示性公告，5月28日股价下跌0.8%
证券之星 · 05-28
南京医药（600713）披露召开2026年第三次临时股东会提示性公告，5月28日股价下跌0.8%
南京医药（600713）披露拟设立大清并购基金并收购大清生物及科健科技股权，5月26日股价下跌0.59%
证券之星 · 05-26
南京医药（600713）披露拟设立大清并购基金并收购大清生物及科健科技股权，5月26日股价下跌0.59%
每周股票复盘：南京医药（600713）拟出资4.5亿参与设立大清并购基金
证券之星 · 05-24
每周股票复盘：南京医药（600713）拟出资4.5亿参与设立大清并购基金
南京医药（600713）披露召开2026年第三次临时股东会的通知，5月21日股价下跌1.96%
证券之星 · 05-21
南京医药（600713）披露召开2026年第三次临时股东会的通知，5月21日股价下跌1.96%
加载更多
公司概况
公司名称：
南京医药集团股份有限公司
所属行业：
零售业
上市日期：
1996-07-01
主营业务：
南京医药集团股份有限公司的主营业务是药品配送、批发、零售及医疗器械配送、批发、医药物流服务和互联网药品零售。公司的主要产品是医药批发、医药零售、医药“互联网+”、医药第三方物流服务。公司现居2024年国内医药流通行业规模排名第7位；2025年《财富》中国500强第307位，较上年排名上升11位。公司亦曾荣获“全国医药流通创新示范企业”称号，是第一批“全国供应链创新与应用示范企业”。
发行价格：
5.98
{"stockData":{"symbol":"600713","market":"SH","secType":"STK","nameCN":"南京医药","latestPrice":5.16,"timestamp":1787554801000,"preClose":5.2,"halted":0,"volume":10295000,"delay":0,"changeRate":-0.0077,"floatShares":1290000000,"shares":1308000000,"eps":0.4756,"marketStatus":"已收盘","change":-0.04,"latestTime":"08-24 15:00:00","open":5.21,"high":5.22,"low":5.13,"amount":53112900,"amplitude":0.0173,"askPrice":5.17,"askSize":928,"bidPrice":5.16,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.4756,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.2,"symbolType":"stock","openAndCloseTimeList":[[1787535000000,1787542200000],[1787547600000,1787554800000]],"highLimit":5.72,"lowLimit":4.68,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1308164032,"isCdr":false,"pbRate":0.92,"roa":"--","peRate":10.849453,"roe":"2.4%","epsLYR":0.48,"committee":0.431996,"marketValue":6750000000,"turnoverRate":0.008,"status":1,"floatMarketCap":6655000000},"requestUrl":"/m/hq/s/600713","defaultTab":"news","newsList":[{"id":"2661117202","title":"每周股票复盘：南京医药（600713）非独立董事离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2661117202","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661117202?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:53","pubTimestamp":1787424788,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，南京医药报收于5.2元，较上周的5.39元下跌3.53%。本周，南京医药8月20日盘中最高价报5.48元。公司公告汇总南京医药集团股份有限公司于2026年8月20日收到非独立董事左翔元先生提交的书面辞职报告，因其工作变动原因，申请辞去公司第十届董事会董事、董事会审计与风险控制委员会、薪酬与绩效考核委员会委员职务，辞去上述职务后不在公司担任任何职务。公司董事会将尽快履行增补非独立董事的法定程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296584","title":"南京医药（600713）披露非独立董事离任公告，8月21日股价下跌3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296584","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661296584?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:15","pubTimestamp":1787321717,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，南京医药报收于5.2元，较前一交易日下跌3.17%，最新总市值为68.02亿元。该股当日开盘5.29元，最高5.29元，最低5.15元，成交额达1.05亿元，换手率为1.57%。近日，南京医药发布《关于公司非独立董事离任的公告》。其辞职未导致公司董事会成员低于法定最低人数，辞职报告自送达公司时生效。公司董事会将尽快履行增补非独立董事的法定程序。左翔元先生不存在未履行完毕的公开承诺，且未持有公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100045404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","600713","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230773","title":"每周股票复盘：南京医药（600713）发行两期融资券共10亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230773","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230773?lang=zh_cn&edition=full","pubTime":"2026-07-19 03:06","pubTimestamp":1784401571,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，南京医药报收于5.14元，较上周的5.09元上涨0.98%。南京医药集团股份有限公司于2026年7月13日发行2026年度第十期超短期融资券，发行总额5亿元，实际发行总额5亿元，募集资金已于2026年7月14日到账，将用于补充流动资金和偿还银行贷款。南京医药集团股份有限公司发布2024年度第二期中期票据2026年付息公告，债券简称24南京医药MTN002，代码102483420.IB，发行总额10亿元，期限5年，起息日为2024年8月9日，当前债券余额10亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900001046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651459913","title":"南京医药（600713）披露2026年度第十期超短期融资券发行结果公告，7月15日股价上涨0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651459913","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651459913?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:38","pubTimestamp":1784108322,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，南京医药报收于5.41元，较前一交易日上涨0.56%，最新总市值为70.77亿元。该股当日开盘5.26元，最高5.52元，最低5.26元，成交额达2.17亿元，换手率为3.1%。公告显示，公司于2026年7月13日发行了2026年度第十期超短期融资券，发行总额为5亿元，实际发行总额5亿元，募集资金已于2026年7月14日到账，将用于补充流动资金和偿还银行贷款。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500034057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0209","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651341110","title":"南京医药（600713）披露2026年度第二期中期票据发行结果公告，7月13日股价上涨0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651341110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651341110?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:36","pubTimestamp":1783953378,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，南京医药报收于5.12元，较前一交易日上涨0.59%，最新总市值为66.98亿元。该股当日开盘5.09元，最高5.17元，最低5.07元，成交额达7565.97万元，换手率为1.14%。近日，南京医药集团股份有限公司披露《2026年度第二期中期票据发行结果公告》。公告显示，公司于2026年7月9日发行2026年度第二期中期票据，发行总额为5亿元，实际发行总额5亿元，发行利率1.68%，起息日为2026年7月10日，兑付日为2029年7月10日，期限3年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300040525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154950","title":"每周股票复盘：南京医药（600713）控股子公司签署7.47亿元投资协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154950?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:28","pubTimestamp":1783794490,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，南京医药报收于5.09元，较上周的5.1元下跌0.2%。本周，南京医药7月8日盘中最高价报5.2元。本周关注点来自公司公告汇总：南京医药控股子公司强链一号基金已签署《股权转让及增资协议》，交易金额74,738.9944万元。南京医药关于控股子公司对外投资的进展公告显示，强链一号基金拟收购大清生物44.95%股权和科健科技50.98%股权，投资总额74,738.9944万元。公司已召开董事会审议通过交易对象变更事项，后续将签署正式协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0209","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650350951","title":"南京医药（600713）披露控股子公司对外投资进展暨签署相关投资协议公告，7月10日股价上涨0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650350951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650350951?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:29","pubTimestamp":1783693752,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，南京医药报收于5.09元，较前一交易日上涨0.79%，最新总市值为66.59亿元。该股当日开盘5.01元，最高5.12元，最低4.98元，成交额达6312.35万元，换手率为0.97%。近日，南京医药发布《关于控股子公司对外投资进展暨签署相关投资协议的公告》。公告显示，公司控股子公司强链一号基金拟并购北京大清生物44.95%股权和北京科健科技50.98%股权，交易金额74,738.9944万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649935485","title":"南京医药（600713）披露控股子公司对外投资进展公告，7月7日股价下跌3.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649935485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649935485?lang=zh_cn&edition=full","pubTime":"2026-07-07 22:32","pubTimestamp":1783434738,"startTime":"0","endTime":"0","summary":"截至2026年7月7日收盘，南京医药报收于4.98元，较前一交易日下跌3.68%，最新总市值为65.15亿元。近日，南京医药发布《关于控股子公司对外投资的进展公告》。公告显示，公司控股子公司强链一号基金拟收购大清生物44.95%股权和科健科技50.98%股权，投资总额74,738.9944万元。大清生物交易方案未调整。公司已召开董事会审议通过交易对象变更事项，后续将签署正式协议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700041775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648957794","title":"南京医药：公司后续将从四方面发力优化市值表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2648957794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648957794?lang=zh_cn&edition=full","pubTime":"2026-07-02 15:36","pubTimestamp":1782977782,"startTime":"0","endTime":"0","summary":"证券之星消息，南京医药07月02日在投资者关系平台上答复投资者关心的问题。请问股价低迷是否已推高融资成本、拖累医药配送主业？有无落地的转型、市值改善方案？本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200020400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313704","title":"每周股票复盘：南京医药（600713）南药转债转股价调至4.95元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646313704?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:49","pubTimestamp":1782586150,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，南京医药报收于5.07元，较上周的4.98元上涨1.81%。本周，南京医药6月23日盘中最高价报5.22元。本次分配以总股本1,308,164,032股为基数，共派发现金红利222,387,885.44元。“南药转债”转股价格因权益分派进行调整，由5.12元/股下调至4.95元/股，调整自2026年6月30日起生效。南京医药向不特定对象发行可转换公司债券募集资金10.81亿元，截至2025年末已累计使用10.47亿元，专户余额3240.88万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646809676","title":"南京医药（600713）披露与私募基金合作投资事项进展公告，6月25日股价上涨2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646809676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646809676?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:27","pubTimestamp":1782397636,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，南京医药报收于5.18元，较前一交易日上涨2.17%，最新总市值为67.76亿元。该股当日开盘5.02元，最高5.18元，最低4.92元，成交额达7691.87万元，换手率为1.18%。近日，南京医药集团股份有限公司发布《与私募基金合作投资事项进展公告》。公告显示，公司与私募基金合作投资设立的南京医药集团强链一号股权投资基金有限公司已完成工商注册及基金备案。该基金注册资本75,000万元，公司出资44,925万元，持股59.9%，为控股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645832500","title":"南京医药（600713）发布关于因实施权益分派调整可转债转股价格的公告，6月23日股价上涨4.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645832500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645832500?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:14","pubTimestamp":1782224081,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，南京医药报收于5.2元，较前一交易日上涨4.0%，最新总市值为68.02亿元。近日，南京医药集团股份有限公司发布《关于因实施权益分派调整可转债转股价格的公告》。公告显示，公司因实施2025年年度权益分派，向全体股东每10股派发现金红利1.70元（含税），根据可转债转股价格调整相关规定，将“南药转债”转股价格由5.12元/股调整为4.95元/股。南药转债于2026年6月23日至6月29日停止转股，6月30日起恢复转股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642265120","title":"南京医药跨界投资折戟：一场“已读不回”背后的三大隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2642265120","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642265120?lang=zh_cn&edition=full","pubTime":"2026-06-12 16:36","pubTimestamp":1781253360,"startTime":"0","endTime":"0","summary":"近日，南京医药宣布终止对宁波江丰生物信息技术有限公司的投资计划。这笔历时近半年、旨在打通“医药流通+数字病理”的跨界布局，最终因标的公司“已读不回”、转而接受更高报价而夭折。表面看是一次商业竞争的失利，实则暴露出南京医药在战略执行、财务健康与资本运作方面的多重风险。 南京医药此次拟出资1.2亿元，通过专项基金受让江丰生物22.5%股权，意图切入数字病理赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-06-12/doc-iniccwvu8927908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600713","BK0209","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640692929","title":"股市必读：南京医药（600713）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640692929","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640692929?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:47","pubTimestamp":1780339631,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，南京医药报收于5.12元，上涨2.2%，换手率0.88%，成交量11.3万手，成交额5723.93万元。董秘最新回复投资者： 董秘您好！请问截止5月28号，公司的股东人数是多少？公司通过定期报告披露季度末股东总数，公司2026年3月末股东总数为47,508人。当日关注点来自交易信息汇总：6月1日主力资金净流入89.45万元，占总成交额1.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200002129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640318519","title":"南京医药：公司2026年3月末股东总数为47,508人","url":"https://stock-news.laohu8.com/highlight/detail?id=2640318519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640318519?lang=zh_cn&edition=full","pubTime":"2026-06-01 15:37","pubTimestamp":1780299461,"startTime":"0","endTime":"0","summary":"证券之星消息，南京医药(600713)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止5月28号，公司的股东人数是多少？谢谢南京医药回复：感谢您对公司的关注。公司通过定期报告披露季度末股东总数，公司2026年3月末股东总数为47,508人。谢谢！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100017389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639602324","title":"每周股票复盘：南京医药（600713）拟设并购基金出资不超4.5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2639602324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639602324?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:51","pubTimestamp":1780174268,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，南京医药报收于5.01元，较上周的5.12元下跌2.15%。本周，南京医药5月25日盘中最高价报5.1元。本周关注点公司公告汇总：南京医药拟出资不超过45,000万元参与设立大清并购基金，用于收购大清生物及科健科技股权。此前同类现金管理已到期赎回，本金7,500万元及收益48.75万元均已收回。药品零售板块2025年销售额27.35亿元，同比增长7.5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638166157","title":"南京医药（600713）披露召开2026年第三次临时股东会提示性公告，5月28日股价下跌0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638166157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638166157?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:34","pubTimestamp":1779960867,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，南京医药报收于4.93元，较前一交易日下跌0.8%，最新总市值为64.53亿元。该股当日开盘4.95元，最高4.99元，最低4.88元，成交额达3912.33万元，换手率为0.62%。近日，南京医药集团股份有限公司发布《关于召开2026年第三次临时股东会的提示性公告》。公告显示，公司将于2026年6月8日召开2026年第三次临时股东会，会议采取现场投票与网络投票相结合方式，股权登记日为2026年5月28日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800031577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543762","title":"南京医药（600713）披露拟设立大清并购基金并收购大清生物及科健科技股权，5月26日股价下跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543762","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638543762?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:44","pubTimestamp":1779806660,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，南京医药报收于5.03元，较前一交易日下跌0.59%，最新总市值为65.84亿元。该股当日开盘5.05元，最高5.05元，最低5.0元，成交额达4808.49万元，换手率为0.74%。近日，南京医药发布2026年第三次临时股东会材料。公告显示，公司拟出资不超过45,000万元，与新工产投、新工医疗并购基金共同设立大清并购基金，专项用于收购大清生物44.95%股权和科健科技50.98%股权，并购总金额74,738.9944万元，交易完成后纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","600713"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637737542","title":"每周股票复盘：南京医药（600713）拟出资4.5亿参与设立大清并购基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2637737542","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637737542?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:59","pubTimestamp":1779566348,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，南京医药报收于5.12元，较上周的5.23元下跌2.1%。本周关注点公司公告汇总：南京医药拟出资不超过45,000万元参与设立大清并购基金。公司公告汇总：南京医药将于2026年6月8日召开第三次临时股东会，审议设立大清并购基金等议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600713","BK0250","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637332717","title":"南京医药（600713）披露召开2026年第三次临时股东会的通知，5月21日股价下跌1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637332717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637332717?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:33","pubTimestamp":1779373992,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，南京医药报收于5.0元，较前一交易日下跌1.96%，最新总市值为65.44亿元。该股当日开盘5.08元，最高5.13元，最低5.0元，成交额达5863.52万元，换手率为0.9%。近日，南京医药集团股份有限公司发布《关于召开2026年第三次临时股东会的通知》。公告显示，公司定于2026年6月8日召开2026年第三次临时股东会，会议采取现场投票与网络投票相结合的方式，股权登记日为2026年5月28日。两项议案均涉及关联股东回避表决，并对中小投资者单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","600713"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787571814906,"stockEarnings":[{"period":"1week","weight":-0.0353},{"period":"1month","weight":0.0505},{"period":"3month","weight":0.0497},{"period":"6month","weight":-0.0101},{"period":"1year","weight":-0.0029},{"period":"ytd","weight":-0.0157}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0099},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0433},{"period":"1year","weight":0.0356},{"period":"ytd","weight":-0.016}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"47508人(较上一季度减少3.54%)","perCapita":"27149股","listingDate":"1996-07-01","address":"江苏省南京市雨花台区安德门大街55号2幢","registeredCapital":"130816万元","survey":" 南京医药集团股份有限公司的主营业务是药品配送、批发、零售及医疗器械配送、批发、医药物流服务和互联网药品零售。公司的主要产品是医药批发、医药零售、医药“互联网+”、医药第三方物流服务。公司现居2024年国内医药流通行业规模排名第7位；2025年《财富》中国500强第307位，较上年排名上升11位。公司亦曾荣获“全国医药流通创新示范企业”称号，是第一批“全国供应链创新与应用示范企业”。","listedPrice":5.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南京医药(600713)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南京医药(600713)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南京医药,600713,南京医药股票,南京医药股票老虎,南京医药股票老虎国际,南京医药行情,南京医药股票行情,南京医药股价,南京医药股市,南京医药股票价格,南京医药股票交易,南京医药股票购买,南京医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南京医药(600713)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南京医药(600713)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}